St. Petersburg, FL, United States of America

Kelly Orange

This inventor holds 1 USPTO granted patent. Top assignee: R.p. Scherer Corporation. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelly Orange. Retrieved from https://idiyas.com/inventor/kelly-orange

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelly Orange - Innovator in Pharmaceutical Dosage Forms

Introduction

Kelly Orange is a notable inventor based in St. Petersburg, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of tamper-evident dosage forms. Her innovative approach addresses safety and usability in pharmaceutical products.

Latest Patents

Kelly Orange holds a patent for a "Tamper evident pharmaceutical dosage form." This invention involves a dosage form suitable for pharmaceuticals, nutrient supplements, and food products. It features a soft elastic gelatin capsule containing a colorless clear liquid carrier and an active ingredient. The capsule is designed to be tamper evident by neutralizing its inherent amber/yellow color with edible dyes and pigments, ensuring safety for consumers.

Career Highlights

Kelly is currently employed at R.P. Scherer Corporation, where she continues to work on innovative solutions in the pharmaceutical industry. Her dedication to improving product safety and efficacy has made her a valuable asset to her team.

Collaborations

Kelly collaborates with her coworker, Keith Edward Tanner, to further enhance their research and development efforts. Together, they strive to create safer and more effective pharmaceutical products.

Conclusion

Kelly Orange's contributions to the field of pharmaceuticals through her innovative patent demonstrate her commitment to safety and efficacy in medication delivery. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…